explore -WSS

explore

author：knowledge 2025-09-01 15:10:11 - browse：611

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： What causes osteoarthritis? Researchers study link to brain protein

WSS

Microsoft launches AI tool for clinical documentation through Epic

Methadone doses haven’t kept up in the age of fentanyl

Update the Apgar Score to remove skin color

TikTok, Instagram influencers need more rules for drug ads

Man killed during FBI raid in connection with threats against Biden, other officials

American woman, child freed after being kidnapped in Haiti last month

hotspot

explore

hotspot

Continuity nursing helped my family in our darkest PICU moments

In same hospitals, Black patients receive fewer opioids than white patients

Medical records are filled with copy

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Dog Aging Project founders on what lies ahead after losing funding

In Memoriam: Notable people who died in 2023

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Tori Bowie and the unacceptable rates of Black maternal death

FDA endorses new sterilization method for medical devices

leisure time

CVS is on a mission to consolidate health care. Will it work?

Pumping milk in bathrooms at health conferences is common

A pediatrician calls for Congress to pass the child tax credit deal

NIH trials fail to test meaningful long Covid therapies, experts say

Man killed during FBI raid in connection with threats against Biden, other officials

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

leisure time

knowledge

hotspot

focus